Strides Pharma Science
NSE: STAR · ISIN INE939A01011 · Healthcare
₹1,006.30−29.60 (−2.86%)
Monday 9 November, 13:16 IST. Delayed. Source: Yahoo Finance.
Price chart
₹1,006.30 −29.60 (−2.86%) today
The day
- Previous close
- ₹1,035.90
- Open
- ₹1,025.00
- Day high
- ₹1,039.90
- Day low
- ₹1,005.00
Listed on NSE since 2 February 2000.
Key numbers
- Market value
- ₹9,291.93 Cr
- P/E (trailing)
- 15.61
- EPS (trailing)
- ₹64.57
- Price to book
- 2.72
- Dividend yield
- 0.48%
- Return on equity
- 20.3%
- Debt to equity
- 0.55
- Profit margin
- 11.8%
- Beta
- 0.36
- Volume today
- 1.19 L
- Average volume
- 4.17 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹3,607.67 Cr | ₹-202.64 Cr |
| FY24 | ₹3,730.02 Cr | ₹-70.61 Cr |
| FY25 | ₹4,391.68 Cr | ₹3,593.46 Cr |
| FY26 | ₹4,627.97 Cr | ₹556.19 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹1,430 Cr | ₹131 Cr | +2.6% |
| Q1 FY27Apr–Jun 2026 | ₹1,265 Cr | ₹157 Cr | +57.5% |
| Q4 FY26Jan–Mar 2026Audited | ₹1,323 Cr | ₹127 Cr | +54.4% |
| Q3 FY26Oct–Dec 2025 | ₹1,195 Cr | ₹202 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹1,221 Cr | ₹128 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹1,120 Cr | ₹100 Cr | – |
Source: Strides Pharma Science’s results filed with NSE, consolidated (the whole group). Net profit is the share of Strides Pharma Science’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹1,185 Cr | ₹1,154 Cr |
| Investments | ₹288 Cr | ₹279 Cr |
| Inventories | ₹1,873 Cr | ₹1,635 Cr |
| Owed by customers | ₹1,464 Cr | ₹1,289 Cr |
| Cash and equivalents | ₹137 Cr | ₹189 Cr |
| Total assets | ₹7,489 Cr | ₹6,927 Cr |
| Borrowings | ₹1,847 Cr | ₹1,669 Cr |
| Total liabilities | ₹4,018 Cr | ₹3,778 Cr |
| Shareholders’ equity | ₹3,416 Cr | ₹3,108 Cr |
Source: Strides Pharma Science’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Strides Pharma Science
Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasal sprays, topical formulations, and controlled substances; and therapeutic products, including antivirals, antibiotics, NSAIDs, and allergy treatment. It also provides branded generics, prescription medicines, and over-the-counter products for infectious diseases, pain management, cardiology, and wellness; and prescription generics for anti-infectives, CNS, cardiovascular, gastroenterology, pain management, and specialty products. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
- Industry
- Drug Manufacturers - Specialty & Generic
- Based in
- Bengaluru
- Employees
- 3,535
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Strides Pharma Science in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 5 Per Share
Dividend · ex-date 31 July 2026
- Dividend - Rs 4 Per Share
Dividend · ex-date 22 July 2025
- Demerger
Action · ex-date 6 December 2024
- Dividend - Rs 2.50 Per Share
Dividend · ex-date 9 September 2024
- Dividend - Rs 1.50 Per Share
Dividend · ex-date 4 August 2023
- Dividend - Rs 2.50 Per Share
Dividend · ex-date 5 August 2021 · record date 6 August 2021
- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 24 July 2020 · record date 27 July 2020
- Interim Dividend - Rs 12 Per Share
Dividend · ex-date 22 August 2019 · record date 23 August 2019
Source: NSE. Latest first, 8 of 20.
Information only, not investment advice. Prices are delayed.